Moreover, as eNOS and VEGF play important role for in the vaso-obliterative phase of ROP (Hartnett et al. 2008), we also examined the expression of eNOS and VEGF at P12 in eye exposed to hyperoxia and after KW6002 treatment (P7–12). The gene discussed is NOS3; the disease is retinopathy of prematurity.